Development and validation of a rapid and robust LC-MS/MS method for quantifi-cation of a new oxazolidinone antibiotic MRX-I in human plasma and urine
- VernacularTitle:口恶唑烷酮类新药 MRX-I 在人血浆、尿液浓度超高效液相色谱串联质谱测定方法的建立及验证
- Author:
Miao ZHAO
;
Xiaojie WU
;
Jun HUANG
;
Jicheng YU
;
Jing ZHANG
;
Beining GUO
- Publication Type:Journal Article
- Keywords:
oxazolidinone;
MRX-I;
ultra performance liquid chromatography-tandem mass spectrometry;
method validation
- From:
Chinese Journal of Infection and Chemotherapy
2014;(3):210-215
- CountryChina
- Language:Chinese
-
Abstract:
Objective To establish and validate an ultra performance liquid chromatography-tandem mass spectrometric (UPLC-MS/MS)method for quantification of MRX-I,a new oxazolidinone antibacterial agent,in human plasma and urine.Methods Chromatographic separation was performed on a Waters ACQUITY UPLC BEH C8 column using an isocratic elution.The mo-bile phase consisted of acetonitrile and water (40∶60,v/v).Quantitative analysis was conducted in the multiple reaction moni-toring mode.Linezolid was used as an internal standard.Liquid-liquid extraction with ethyl acetate was used to remove impuri-ties in the plasma and urine samples.The method was validated in terms of matrix effect,recovery,precision,accuracy and stability.Results The calibration curves were linear within the range of 0.005 00-1 .00 mg/L.The lower limit of quantification was 0.005 00 mg/L for both plasma and urine samples.Retention time was less than 1 .5 min for both MRX-I and internal standard in plasma and urine.The ma-trix effect factors of plasma and urine for MRX-I was 90.4%±8.2% and 82.7%±7.9%,respectively.The recovery of MRX-I was 112.8% ± 13.4% from plasma and 105.6% ± 13.4% from urine samples,respectively.The inter- and intra-day accuracy of MRX-I was 98.9%-105.0% and 96.5%-102.6% in plasma samples,and 92.7%-98.6% and 95.1 %-105.7% in urine samples.MRX-I was stable for 24 h at room tem-perature,48 h in automatic sampler after pretreatment,and stable after 3 freeze-thaw cycles in plasma and urine.MRX-I was also stable at-40℃for eight months in plasma and six months in urine,respectively.Conclusions The UPLC-MS/MS method established in this study shows high sensitivity and specificity for determination of MRX-I in human plasma and urine.The re-sults of validation are consistent with the requirement of bioanalytical method validation.
